112566 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
Method for detecting autoprocessed, secreted PCSK9
#1202METHODS AND COMPOSITIONS FOR MODULATING PROSTASIN
#1203Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
#1204LIGAND-CONTAINING MICELLES AND USES THEREOF
#1205Method for determining the course of proteolytic activity
#1206CLEAVAGE OF BIP BY SUBTILASE CYTOTOXIN
#1207PRSS23 AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
#1208Substrates for detecting peptidase activity and methods using the substrates
#1209FERRIC REDUCTASE ACTIVITY OF HISTOPLASMA CAPSULATUM Y-GLUTAMYLTRANSFERASE
#121027877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
#1211METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES
#1212Method for the detection of post-translational modifications
#1213ANTIBODY AND USES THEREOF
#1214FRET protease assays for clostridial toxins
#1215FRET protease assays for clostridial toxins
#1216FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY
#1217FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY
#1218Fret protease assays for clostridial toxins
#1219FRET protease assays for clostridial toxins
#1220Bioluminescent detection of cyanohydroxy benzothiazole compounds
#1221FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS
#1222Methods for identifying HCV protease inhibitors
#1223PROCESS AND KIT FOR MEASURING THE CONDITION OF THE FIBRINOLITIC SYSTEM
#1224METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
#1225Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
#1226Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate
#1227Detection of protease and protease activity using a single nanoscrescent SERS probe
#1228Assessment of patients with sepsis to determine a requirement for therapeutic intervention with an anti-inflammatory and/or anticoagulatory agent
#1229PROTEIN INTERACTION REPORTER AGENTS AND METHODS FOR USING SAME
#1230Fusion proteins and polynucleotide constructs to measure protein turn-over
#1231Detection of specific binding reactions using magnetic labels
#1232Methods and compositions for reducing amyloid beta levels
#1233GREEN TEA POLYPHENOL ALPHA SECRETASE ENHANCERS AND METHODS OF USE
#1234Enzymatic substrates derived from phenoxazinone and their use as developers in detection of microorganisms with peptidase activity
#1235Cross-reactive sensors
#1236Method for the detection of enzymatic reactions
#1237RAPID DETECTION OF SULFHYDRYL COMPOUNDS USING A PAPAIN BASED ASSAY
#1238Method for Determining the Activity of a Protease in a Sample
#1239Systems and methods for in vivo measurement of interstitial biological activity, processes and/or compositions
#1240Predicting heart failure following myocardial infarction by protease and protease inhibitor profiling
#1241Method for determining the ratio of two distinct peptides or polynucleic acids
#1242METHODS OF DIAGNOSIS AND TREATMENT FOR METABOLIC DISORDERS
#1243BIOMARKER FOR ASSESSING RESPONSE TO CHYMASE TREATMENT
#1244Electrochemical Assay for the Detection of Enzymes
#1245Detecting infection in reduced pressure wound treatment
#1246Assay For Tissue Factor And Factor Vlla
#1247HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES
#1248METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME
#1249MEANS AND METHODS FOR MODULATING STEM CELL MOBILIZATION
#1250Method for screening a protease
#1251Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
#1252Methods and apparatus for performing retention-time matching
#1253Method of reducing the viscosity of mucus
#1254Mass spectrometric determination of blood enzyme activity
#1255MICROBIAL MARKERS OF INFLAMMATORY BOWEL DISEASE
#1256METHOD OF MEASURING NEPRILYSIN ACTIVITY
#1257METHOD FOR IDENTIFYING BPLP AND OPIORPHIN AGONISTS OR ANTAGONISTS
#1258Method for detecting and analyzing protein interactions in-vivo
#1259High-sensitivity proteolysis assay
#1260Method for Testing Alzheimer's Disease by Measuring Degradation Rate of B-Amyloid in Blood and Diagnostic Reagent
#1261Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy
#1262METHODS FOR TREATING PATHOLOGICAL NEOVASCULARIZATION
#1263COMPOSITIONS AND METHODS USING SAME FOR THE DETECTION OF VIRUSES
#1264Novel genes encoding novel proteolytic enzymes
#1265Method of determining chymase activity with secretory leukocyte protease inhibitor
#1266Distinguishing cells in a sample by inactivating extracellular enzyme before releasing intracellular enzyme
#1267CELL-BASED PCSK9 SCREENING ASSAY
#1268Nonluminogenic assay for living cells
#1269Processing of EphA4 polypeptide by γ-secretase activity
#1270Process for determining S-nitrosothiols in biological fluids
#1271METHOD FOR DETECTING MICROORGANISM
#1272Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer
#1273In vitro estimation of in vivo half-life binding proteins
#1274UBIQUITIN LIGASE ASSAY
#1275VISUALIZATION AND QUANTITIATION OF CELLULAR CYTOTOXICITY USING CELL-PERMEABLE FLUOROGENIC PROTEASE SUBSTRATES AND CASPASE ACTIVITY INDICATOR MARKERS
#1276Analysis of amino acid copolymer compositions
#1277MASP-2, A COMPLEMENT FIXING ENZYME, AND USES FOR IT
#1278Devices for the detection of the presence and/or activity of proteases in biological samples
#1279Methods for Determining the Cleavability of Substrates
#1280Assays for detecting pregnancy-associated glycoproteins
#1281Selective substrates for matrix metalloproteinases
#1282Chemistry used in biosensors
#1283Method for preventing degradation of diacetylpolyamine
#1284PROTEASE DETECTION MATERIAL, SET OF PROTEASE DETECTION MATERIALS, AND METHOD FOR MEASURING PROTEASE
#1285Use of MRP 8/14 levels for discrimination of individuals at risk of acute coronary syndromes
#1286Peptides for modulating innate immunity
#1287Elastase inhibitor and acute leukemia
#1288Methods of isolating dermal papilla cells
#1289NON-INVASIVE ENZYME SCREEN FOR TISSUE REMODELLING-ASSOCIATED CONDITIONS
#1290Mitotic Progression Genes and Methods of Modulating Mitosis
#1291Generation and use of a catalog of polypeptide-related information for chemical analyses
#1292Method to Assess Breast Cancer Risk
#1293COMPOUNDS FOR ENZYME INHIBITION
#1294METHODS FOR DIAGNOSIS OF ACUTE CORONARY SYNDROME
#1295Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof
#1296BIOLOGICAL ENTITIES AND THE USE THEREOF
#1297HALOGEN PHOSPHONATE MONOESTERS
#1298BIOLOGICAL ENTITIES AND THE USE THEREOF
#1299PROTEASE DETECTION PRODUCT
#1300Method for determination of allergen in environment and kit for simple quantification of allergen
#1301Liquid tissue preparation from histopathologically processed biological samples, tissues and cells
#1302Method for quantification of allergens
#1303Testing a mammal for presence, progression or stage of a shock condition
#1304Method for identifying autistic individuals amenable to digestive enzyme therapy
#1305Diagnostic assay for spongiform encephalopathies
#1306Methods of Screening for Atherosclerosis
#1307Cell-permeable fluorescent proteins
#1308METHOD OF SCREENING USING c-MET, A NOVEL SUBSTRATE FOR GAMMA-SECRETASE
#1309HCV NS3-NS4 protease resistance mutants
#1310NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
#1311Diagnosis of fertility conditions using a serine protease
#1312METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#1313Tomoregulin-2-antibody compositions and methods for the diagnosis and treatment of Alzheimer's disease
#1314Method for determining inhibitors of neurotrypsin
#1315Agents for Imaging Apoptosis
#1316Methods for inhibiting VEGF-D
#1317Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
#1318Alzheimer's Disease Secretase, APP Substrates Thereof, and Uses Thereof
#1319Methods for determining absorption of cobalamin or analogues thereof
#1320Resonance energy transfer based detection of nosocomial infection
#1321Thymic stromal lymphpoietin promoter and use therefor
#1322METHODS AND MEANS FOR SCREENING FOR RHOMBOID ACTIVITY
#1323METHODS FOR DETERMINING THE ACTIVITY OF ADAM-TS PROTEASES USING THIOPEPTOLIDES
#1324Methods, kits, and compositions for detecting enzyme activity
#1325Modified peptide substrate
#1326Enzyme substrate comprising a functional dye and associated technology and methods
#1327Method of screening for compounds which affect the processing of EphA4 by γ-secretase
#1328Method for assaying glycated albumin
#1329Uses of antileukoprotease in carcinoma
#1330Methods of measuring cell viability in tissue engineered products
#1331CD10-activated prodrug compounds
#1332Methods of generating and screening for proteases with altered specificity
#1333Fungal dipeptidyl peptidase IV (DPPIV) enzyme for reagent use
#1334SCREENING PROTEINASE MODULATORS USING A CHIMERIC PROTEIN AND SKI-I PROPROTEIN CONVERTASE SUBSTRATES AND INHIBITORS
#1335Method for Accessing Microbial Diversity
#1336Method for treating pervasive development disorders
#1337METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#1338Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
#1339Protease screening methods and proteases identified thereby
#1340High Affinity Nucleic Acid Ligands To Lectins
#1341Method for determining if a subject having type II diabetes has a kidney disorder
#1342Cell compositions useful for cell-based FRET assays for clostridial toxins
#1343Imaging agents and methods of imaging NAALADase or PSMA
#1344DEVICE FOR DETECTING AN ENZYME IN A SAMPLE
#1345Methods for determining human immunodeficiency virus type 2 (HIV-2) protease sensitivity or resistance to antivirals utilizing an inducible yeast expression system
#1346METHOD OF IDENTIFYING COMPOUNDS THAT MODULATE CASPASE 9 ACTIVITY VIA USE OF A KOSMOTROPIC SALT
#1347Treatment of neurodegenerative diseases by the use of scd4 inhibitors
#1348Method of Detecting Kidney Dysfunction
#1349Method and Apparatus for Measuring Protein Post-Translational Modification
#1350Protein cleavage method and use thereof
#1351Compositions and Methods For Signal Generation
#1352Homogeneous luminescence bioassay
#1353METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION
#1354Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
#1355Substrate peptide sequences for plague plasminogen activator and uses thereof
#1356METHODS AND COMPOSITIONS FOR DIAGNOSIS AND IMMUNOTHERAPY OF POLLEN ALLERGY
#1357COMPOSITIONS AND METHODS FOR REGULATING INTRAMEMBRANE PROTEASES
#1358Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases
#1359FLUOROGENIC ENZYME ACTIVITY ASSAY METHODS AND COMPOSITIONS USING FRAGMENTABLE LINKERS
#1360IDENTIFICATION OF NOVEL POST-TRANSLATIONAL PROTEIN MODIFICATIONS
#1361FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS
#1362Aromatic triamide-lanthanide complexes
#1363MONITORING ENZYME MIXTURES
#1364Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
#1365Magnetic-nanoparticle conjugates and methods of use
#1366GENETIC SELECTION SYSTEM TO IDENTIFY PROTEASES, PROTEASE SUBSTRATES AND PROTEASE INHIBITORS
#1367PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS
#1368PARTICLE FOR DETECTING ENZYME ACTIVITY, METHOD FOR DETECTING THE ENZYME ACTIVITY AND ENZYME ACTIVITY DETECTION DEVICE BY THE USE THEREOF
#1369High throughput sarcomeric assay
#1370Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
#1371Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents
#1372Diagnostics and Therapeutics for Diseases Associated With Fibroblast Activation Protein (Fap)
#1373Methods of screening an agent for an activity in an isolated eye of a teleost
#1374Methods for the early diagnosis of ovarian cancer
#1375Methods compositions and compound assays for inhibiting amyloid-beta protein production
#1376METHOD FOR DETERMINING PLASMINOGEN ACTIVATOR INHIBITOR
#1377Method for Determining Condition of Disseminated Intravascular Coagulation
#137817867, a novel human aminopeptidase
#1379Assays and methods using biomarkers
#1380Novel Integrin Ligand ITGL-TSP
#1381Fluorescence polarization assays for determining clostridial toxin activity
#1382Fluorescence polarization assays for determining clostridial toxin activity
#1383Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds
#1384Compositions, methods, and kits for assaying complement activation
#1385Self-Assembling Nanoparticle Conjugates
#1386Substrates and assays for beta-secretase activity
#1387Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using
#1388High-throughput assay for virus entry and drug screening
#1389SALICYLAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS
#1390Enzymatic substrates derived from phenoxazinone and their use as developer in detection of microorganisms with peptidase activity
#1391Fluorescence polarization assays for determining clostridial toxin activity
#1392Fluorescence polarization assays for determining clostridial toxin activity
#1393Method for the detection, identification and/or quantification of microoganisms with peptidase activity using phenoxazinone derivatives as enzyme substrates
#1394Method for the functional determination of mannan-binding-lectin associated serine proteases (MASPs) and complexes thereof
#1395Screening method for protein variants using mass spectrometry
#1396Swatch for testing the washing performance of an enzyme
#1397Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
#1398Assay Method
#1399Method for quantifying biomolecules conjugated to a nanoparticle
#1400Screening Method Identifying Protease Secretion-Deficient Mutants of Microorganisms
#1401Salivary Protease Assays for Identifying Increased Risk of Preterm Delivery Induced by Premature Rupture of Fetal Membranes
#1402Matriptase, a serine protease and its applications
#1403Diagnostics and Therapeutics for Diseases Associated with Arginyl Aminopeptidase (Aminopeptidase B)-Like 1 (Rnpepl1)
#1404Methods and compositions for determination of glycated proteins
#1405Apparatuses and methods for determining protease activity
#1406IL-1F6 polypeptides
#140727877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
#1408HOMOGENEOUS ASSAY FOR ENZYMATIC ACTIVITY
#1409Optical detector for enzyme activation
#1410Process for the preparation of "Urchym" a urease and alpha-chymotrypsin enzyme inhibitory drug
#1411Kit for detection of hemolytic
#1412Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
#1413Method of Screening Transmembrane Enzyme Inhibitory Substance
#1414Methods of treating pervasive development disorders
#1415PORTABLE SENSOR ARRAY SYSTEM
#1416XANTHENE DYES
#1417DIAGNOSING BREAST CANCER BY SEPRASE LEVEL
#1418Method for Examing Interstitital Cystitis
#1419GFP-SNAP25 fluorescence release assay for botulinum toxin protease activity
#1420SEPARATION DEVICES AND METHOD FOR SEPARATING PHOSPHORYLATED PEPTIDES AND PROTEINS
#1421Process to determine enzyme activity
#1422Compositions for the detection of enzyme activity in biological samples and methods of use thereof
#1423Method for quantitative determination of glycated protein and kit for quantitative determination of the same
#1424Diagnostic method for chronic fatigue syndrome by measuring elastase
#1425Method for the detection of proteolytic enzymes
#1426Assays and methods using biomarkers
#1427GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity
#1428Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
#1429GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity
#1430Inhibitors of USP1 Deubiquitinating Enzyme Complex
#1431GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity
#1432Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 6 (Dpp6)
#1433PROCESS FOR GENERATING SEQUENCE-SPECIFIED PROTEASES BY DIRECTED EVOLUTION AND USE THEREOF
#1434Monitoring Enzyme-Substrate Reactions
#1435OPTICAL PROBES AND ASSAYS
#1436Proteome Standards for Mass Spectrometry
#1437Medium for the Specific Detection of Resistant Microorganisms
#1438Enzyme detection techniques
#1439CASPASE-8 INTERACTING PROTEINS
#1440Methods and kits for detecting and measuring ADAMTS13/FXI complexes
#1441KINASE AND UBIQUINATION ASSAYS
#1442Monitoring of Wounds by Measurement of Protease and Protease Inhibitor Levels in Wound Fluids
#1443METHODS FOR TREATMENT OF INFLAMMATORY DISEASE AND CHLAMYDIA INFECTIOUS DISEASE
#1444PROTEASOMAL PEPTIDASE ACTIVITY AND THE USE THEREOF IN CLINICAL APPLICATIONS
#1445Methods of screening for inhibitors of antiplasmin cleaving enzyme
#1446Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#1447Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#1448Kits and peptides for transferases
#1449Hemoglobin A1c determination method, enzyme to be used therefor, and production method thereof
#1450Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#1451Dendritic cell transmembrane serine protease
#1452Substrates and Assays for Beta Secretase Activity
#1453PROTEASE INHIBITORS AND METHOD OF SCREENING THEREOF
#1454Method of treating HIV infection
#1455Construction of gold nanoparticle-based peptide chip, and assaying enzyme activity and inhibitor effect using secondary ion mass spectrometric analysis thereof
#1456Synthetic substrates and inhibitors with enhanced specificity
#1457Dual-labeled molecular constructs for detection of biochemical reactions
#1458ASSAYS FOR IDENTIFYING UBIQUITIN AGENTS AND FOR IDENTIFYING AGENTS THAT MODIFY THE ACTIVITY OF UBIQUITIN AGENTS
#1459FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) ASSAYS FOR CLOSTRIDIAL TOXIN ACTIVITY
#1460METHODS FOR CARBOXYPEPTIDASES
#1461Method and Apparatus for Measuring Enviromental Allergen
#1462Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
#1463Assay for ubiquitin mediated proteolysis
#1464Method for accessing microbial diversity
#1465FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS
#1466FLAVIVIRUS PROTEASE SUBSTRATES AND INHIBITORS
#1467Method for incorporation of two oxygen atoms into digested peptides using peptidases
#1468FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS
#1469Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
#1470Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties
#1471Treatment of Neurodegenerative Diseases by the Use of Degs Inhibitors
#1472Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3)
#1473Compositions and method for regulating ubiquitin-specific processing proteases
#1474Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1)
#1475Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
#1476Nananoic acid derivatives as dipeptidyl peptidase inhibitors
#1477Methods for quantitative proteome analysis of glycoproteins
#1478Colorimetric substrates, colorimetric sensors, and methods of use
#1479Novel affinity labels
#1480Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance
#1481System for detecting protease
#1482Diagnostics and Therapeutics for Diseases Associated with Putative Cysteine Protease 1 (Prs1)
#1483Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
#1484KINASE AND UBIQUINATION ASSAYS
#1485Diagnosis and prognosis of dipeptidyl peptidase-associated disease states
#1486Method for Screening and Selecting Enzymes
#1487High throughput sarcomeric assay
#1488Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps)
#1489Diagnostics and Therapeutics for Diseases Associated with Tripeptidyl-Peptidase 2(Tpp2)
#1490METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#1491Methods for assessing the efficacy of treatment with a glucocorticoid
#1492COMPOSITIONS AND METHODS FOR DETECTING PROTEASE ACTIVITY
#1493Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 10 (Dpp10)
#1494Diagnostics and Therapeutics for Diseases Associated with Plasma Kallikrein (KLKB1)
#1495Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
#1496ASSAYS AND PEPTIDE SUBSTRATE FOR DETERMINING AGGRECAN DEGRADING METALLO PROTEASE ACTIVITY
#1497Ethanoic acid derivatives as dipeptidyl peptidase inhibitors
#1498Device and methods for liquid crystal-based bioagent detection
#1499Hepatitis C virus variants
#1500Reagent containing protease reaction promoter and/or colorant stabilizer